PCBP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.62458935193399E-12 |
Normal-vs-Stage2 |
9.83940000000016E-05 |
Normal-vs-Stage3 |
1.70369999996645E-07 |
Normal-vs-Stage4 |
2.971100E-04 |
Stage1-vs-Stage2 |
3.393400E-01 |
Stage1-vs-Stage3 |
4.097600E-03 |
Stage1-vs-Stage4 |
9.88769999999972E-05 |
Stage2-vs-Stage3 |
3.111800E-01 |
Stage2-vs-Stage4 |
1.048370E-01 |
Stage3-vs-Stage4 |
3.153800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
<1E-12 |
Normal-vs-AfricanAmerican |
7.89130000000693E-05 |
Normal-vs-Asian |
1.003960E-01 |
Caucasian-vs-AfricanAmerican |
9.790400E-01 |
Caucasian-vs-Asian |
9.639400E-01 |
AfricanAmerican-vs-Asian |
9.763600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.88498130835069E-15 |
Normal-vs-Female |
1.62447832963153E-12 |
Male-vs-Female |
9.67659999999704E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.730430E-02 |
Normal-vs-Age(41-60Yrs) |
1.62470037423645E-12 |
Normal-vs-Age(61-80Yrs) |
1.62614366416847E-12 |
Normal-vs-Age(81-100Yrs) |
1.837610E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.655000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.466600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.433800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.428600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.214000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.379400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.81700000010532E-07 |
Normal-vs-Grade 2 |
<1E-12 |
Normal-vs-Grade 3 |
1.55098156540134E-13 |
Normal-vs-Grade 4 |
7.644000E-02 |
Grade 1-vs-Grade 2 |
2.970000E-02 |
Grade 1-vs-Grade 3 |
3.380700E-04 |
Grade 1-vs-Grade 4 |
1.94820000021245E-07 |
Grade 2-vs-Grade 3 |
2.538200E-03 |
Grade 2-vs-Grade 4 |
2.16040000333706E-08 |
Grade 3-vs-Grade 4 |
1.104020E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
<1E-12 |
Normal-vs-ccB subtype |
1.980770E-01 |
ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.42659275690494E-14 |
Normal-vs-N1 |
5.415400E-01 |
N0-vs-N1 |
3.984200E-03 |
|
|